YAP1 and hepatocellular carcinoma: In a clinical study, the selective colocalization of β-catenin and YAP1 in the nucleus was identified in approximately 80% of hepatocellular carcinoma patients but not in patients with hepatocellular carcinoma or cholangiocarcinoma (Tao et al., 2014).